-
Signature
-
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen
-
Issuer symbol
-
EVLV
-
Transactions as of
-
15 Oct 2025
-
Net transactions value
-
-$647,575
-
Form type
-
4
-
Filing time
-
17 Oct 2025, 16:52:21 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Ellenbogen Michael |
Director |
C/O EVOLV TECHNOLOGIES, INC., 500 TOTTEN POND ROAD, 4TH FLOOR, WALTHAM |
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen |
16 Oct 2025 |
0001869206 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EVLV |
Class A Common Stock |
Options Exercise |
$19,379 |
+80,745 |
+3.9% |
$0.2400 |
2,164,706 |
15 Oct 2025 |
Direct |
|
| transaction |
EVLV |
Class A Common Stock |
Sale |
$666,954 |
-80,745 |
-3.7% |
$8.26 |
2,083,961 |
15 Oct 2025 |
Direct |
F1, F2 |
| holding |
EVLV |
Class A Common Stock |
|
|
|
|
|
151,135 |
15 Oct 2025 |
Held by Family Horizon Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EVLV |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-80,745 |
-5% |
$0.000000 |
1,542,974 |
15 Oct 2025 |
Class A Common Stock |
80,745 |
$0.2400 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: